Correction to: A double-blind, placebo-controlled, randomized trial of PXT3003 for the treatment of Charcot–Marie–Tooth type 1A (Orphanet Journal of Rare Diseases, (2021), 16, 1, (433), 10.1186/s13023-021-02040-8)

Shahram Attarian, Peter Young, Thomas H. Brannagan, David Adams, Philip Van Damme, Florian P. Thomas, Carlos Casanovas, Jafar Kafaie, Céline Tard, Maggie C. Walter, Yann Péréon, David Walk, Amro Stino, Marianne de Visser, Camiel Verhamme, Anthony Amato, Gregory Carter, Laurent Magy, Jeffrey M. Statland, Kevin Felice

Research output: Contribution to journalComment/debatepeer-review

Abstract

Following publication of the original article [1], we have been notified that we should add one more author to the authors’ group: Jafar Kafaie 8 8 Department of Neurology, Saint Louis University School of Medicine, St. Louis, USA The original article was updated.

Original languageEnglish (US)
Article number142
JournalOrphanet Journal of Rare Diseases
Volume19
Issue number1
DOIs
StatePublished - Dec 2024

Bibliographical note

Publisher Copyright:
© The Author(s) 2024.

PubMed: MeSH publication types

  • Published Erratum

Fingerprint

Dive into the research topics of 'Correction to: A double-blind, placebo-controlled, randomized trial of PXT3003 for the treatment of Charcot–Marie–Tooth type 1A (Orphanet Journal of Rare Diseases, (2021), 16, 1, (433), 10.1186/s13023-021-02040-8)'. Together they form a unique fingerprint.

Cite this